Despite COVID-19 vaccinations, CDC warns U.S. is 'not out of the woods' - Fox Business

Walensky, citing the latest data from the agency, said that the recent declines in COVID-19 cases have leveled off at roughly 70,000 cases per day.

The goal in those first 100 days has always been to sort of make sure that we are in a place to be out of this pandemic," Walensky said. "At 70,000 cases per day, we’re not in that place right now. .

CDC SIGNS OFF ON JOHNSON & JOHNSON'S SINGLE-DOSE COVID-19 VACCINE.

On Sunday, Walensky signed off on a recommendation from the agency's Advisory Committee on Immunization Practices (ACIP) that drugmaker Johnson & Johnson's COVID-19 vaccine should be used for emergency use for individuals ages 18 and older.

Johnson & Johnson's vaccine is the third for the United States, following previous emergency use approvals for vaccines manufactured by Pfizer and BioNTech and Moderna. Unlike the other two available vaccines, Johnson & Johnson's requires a single dose and does not need to be kept in a freezer.

According to an analysis by the FDA, Johnson & Johnson's vaccine was about 67% effective in preventing moderate to severe cases within 14 days after dosing and 66% effective against severe to critical cases after 28 days.

In addition, the vaccine was approximately 77% effective in preventing severe or critical COVID-19 occurring at least 14 days after vaccination and 85% effective in preventing severe or critical COVID-19 occurring at least 28 days after vaccination.

The ACIP does not state a preference for a particular COVID-19 vaccine.

According to the latest CDC data, more than 76 million COVID-19 vaccines have been administered in the United States, with nearly 50 million Americans receiving at least one dose of a COVID-19 vaccine.

Deliveries of Johnson & Johnson's initial supply of 3.9 million vaccine doses to state health departments, pharmacies, federally qualified health centers and community vaccination centers across the country are expected as early as Tuesday.